Papaverine as an antiarrhythmic agent.
D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D014700:Verapamil; D010208:Papaverine; D011802:Quinidine; D011342:Procainamide